{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T19:33:36Z","timestamp":1783452816698,"version":"3.55.0"},"reference-count":9,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1111\/bjd.16045","type":"journal-article","created":{"date-parts":[[2017,10,9]],"date-time":"2017-10-09T11:16:42Z","timestamp":1507547802000},"page":"1196-1198","source":"Crossref","is-referenced-by-count":33,"title":["Low-dose naltrexone: a novel treatment for Hailey-Hailey disease"],"prefix":"10.1093","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7626-3574","authenticated-orcid":false,"given":"V.","family":"Campbell","sequence":"first","affiliation":[{"name":"Department of Dermatology; Wing D; Belfast City Hospital; Lisburn Rd Belfast BT9 7AB U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"McGrath","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Wing D; Belfast City Hospital; Lisburn Rd Belfast BT9 7AB U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Corry","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Wing D; Belfast City Hospital; Lisburn Rd Belfast BT9 7AB U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,23]]},"reference":[{"key":"10.1111\/bjd.16045-BIB0001|bjd16045-cit-0001","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1001\/archderm.1939.01480220064005","article-title":"Familial benign chronic pemphigus","volume":"39","author":"Hailey","year":"1939","journal-title":"Arch Dermatol Syphilol"},{"key":"10.1111\/bjd.16045-BIB0002|bjd16045-cit-0002","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1365-2133.2004.05904.x","article-title":"Calcium pumps and keratinocytes: lessons from Darier's disease and Hailey-Hailey disease","volume":"150","author":"Dhitavat","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16045-BIB0003|bjd16045-cit-0003","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1365-2133.1992.tb00658.x","article-title":"Hailey-Hailey disease: the clinical features, response to treatment and prognosis","volume":"126","author":"Burge","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.16045-BIB0004|bjd16045-cit-0004","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1177\/1352458510366857","article-title":"The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial","volume":"16","author":"Sharafaddinzadeh","year":"2010","journal-title":"Mult Scler"},{"key":"10.1111\/bjd.16045-BIB0005|bjd16045-cit-0005","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1529-8019.2005.00035.x","article-title":"Pharmacologic advances in the systemic treatment of itch","volume":"18","author":"Summey","year":"2005","journal-title":"Dermatol Ther"},{"key":"10.1111\/bjd.16045-BIB0006|bjd16045-cit-0006","first-page":"533","article-title":"Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases","volume":"41","author":"Metze","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/bjd.16045-BIB0007|bjd16045-cit-0007","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2165\/00128071-200405020-00003","article-title":"Prurigo","volume":"5","author":"Wallengren","year":"2004","journal-title":"Am J Clin Dermatol"},{"key":"10.1111\/bjd.16045-BIB0008|bjd16045-cit-0008","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.mehy.2008.06.048","article-title":"Low-dose naltrexone for disease prevention and quality of life","volume":"72","author":"Brown","year":"2009","journal-title":"Med Hypotheses"},{"key":"10.1111\/bjd.16045-BIB0009|bjd16045-cit-0009","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s10067-014-2517-2","article-title":"The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain","volume":"33","author":"Younger","year":"2004","journal-title":"Clin Rheumatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.16045","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.16045\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:30:12Z","timestamp":1676367012000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/178\/5\/1196\/6752993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,23]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.16045","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2,23]]}}}